Plasma 25-hydroxyvitamin D and rickets in low birthweight babies. 1983

C McCowen, and E Hey

UI MeSH Term Description Entries
D007230 Infant, Low Birth Weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. Low Birth Weight,Low-Birth-Weight Infant,Birth Weight, Low,Birth Weights, Low,Infant, Low-Birth-Weight,Infants, Low-Birth-Weight,Low Birth Weight Infant,Low Birth Weights,Low-Birth-Weight Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012279 Rickets Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances. Rachitis,Rachitides
D015652 25-Hydroxyvitamin D 2 9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3. 25-Hydroxyergocalciferol,25-Hydroxycalciferol,25-Hydroxyvitamin D2,9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol,Ercalcidiol,25 Hydroxycalciferol,25 Hydroxyergocalciferol,25 Hydroxyvitamin D 2,25 Hydroxyvitamin D2

Related Publications

C McCowen, and E Hey
November 1982, Archives of disease in childhood,
C McCowen, and E Hey
November 1977, Pediatrics,
C McCowen, and E Hey
September 1979, Lancet (London, England),
C McCowen, and E Hey
February 1976, Pediatrics,
C McCowen, and E Hey
April 1978, Lancet (London, England),
C McCowen, and E Hey
June 1978, Lancet (London, England),
C McCowen, and E Hey
September 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
C McCowen, and E Hey
September 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
C McCowen, and E Hey
May 2013, Clinical chemistry,
C McCowen, and E Hey
April 1995, Acta paediatrica Japonica : Overseas edition,
Copied contents to your clipboard!